» Articles » PMID: 22031225

Acute Lymphoblastic Leukemia and Developmental Biology: a Crucial Interrelationship

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2011 Oct 28
PMID 22031225
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The latest scientific findings in the field of cancer research are redefining our understanding of the molecular and cellular basis of the disease, moving the emphasis toward the study of the mechanisms underlying the alteration of the normal processes of cellular differentiation. The concepts best exemplifying this new vision are those of cancer stem cells and tumoral reprogramming. The study of the biology of acute lymphoblastic leukemias (ALLs) has provided seminal experimental evidence supporting these new points of view. Furthermore, in the case of B cells, it has been shown that all the stages of their normal development show a tremendous degree of plasticity, allowing them to be reprogrammed to other cellular types, either normal or leukemic. Here we revise the most recent discoveries in the fields of B-cell developmental plasticity and B-ALL research and discuss their interrelationships and their implications for our understanding of the biology of the disease.

Citing Articles

Transcriptional regulation of the non-homologous end joining gene Ligase IV by an intronic regulatory element directs thymocyte development.

Collins P, Estrada M, Gebhardt C, Estrada M, Gebhardt C, Salem M Res Sq. 2025; .

PMID: 39866872 PMC: 11760251. DOI: 10.21203/rs.3.rs-5718046/v1.


Single-cell RNA-seq analysis revealed the stemness of a specific cluster of B cells in acute lymphoblastic leukemia progression.

Wang G, Zhang E, Chen A, Meng D PeerJ. 2024; 12:e18296.

PMID: 39465162 PMC: 11505884. DOI: 10.7717/peerj.18296.


CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current Insights.

Christian S Onco Targets Ther. 2022; 15:1391-1402.

PMID: 36425299 PMC: 9680537. DOI: 10.2147/OTT.S366625.


A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study.

He Y, Wu X, Zhou D, Yang L, Mai H, Wan W Front Oncol. 2022; 12:854798.

PMID: 35425700 PMC: 9002097. DOI: 10.3389/fonc.2022.854798.


Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines.

Leo I, Aswad L, Stahl M, Kunold E, Post F, Erkers T Nat Commun. 2022; 13(1):1691.

PMID: 35354797 PMC: 8967900. DOI: 10.1038/s41467-022-29224-5.


References
1.
Trevino L, Yang W, French D, Hunger S, Carroll W, Devidas M . Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009; 41(9):1001-5. PMC: 2762391. DOI: 10.1038/ng.432. View

2.
Hosking F, Papaemmanuil E, Sheridan E, Kinsey S, Lightfoot T, Roman E . Genome-wide homozygosity signatures and childhood acute lymphoblastic leukemia risk. Blood. 2010; 115(22):4472-7. DOI: 10.1182/blood-2009-09-244483. View

3.
Krivtsov A, Armstrong S . MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007; 7(11):823-33. DOI: 10.1038/nrc2253. View

4.
Miller J, Allman D . The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol. 2003; 171(5):2326-30. DOI: 10.4049/jimmunol.171.5.2326. View

5.
Purton L, Scadden D . Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell. 2008; 1(3):263-70. DOI: 10.1016/j.stem.2007.08.016. View